LOADING

Type to search

Exports of China’s COVID-19 Vaccines Plunge, Hindering the Regime’s ‘Vaccine Diplomacy’

Cansino CCP Virus China China Business & Economy Chinese Regime covax INSIDE CHINA International International Relations sinopharm Sinovac vaccine diplomacy World

Exports of China’s COVID-19 Vaccines Plunge, Hindering the Regime’s ‘Vaccine Diplomacy’

Share

The export of Chinese-made COVID-19 vaccines has dropped significantly this year due to its low effectiveness, especially against new mutations of the virus, hampering the Chinese communist regime’s campaign of “vaccine diplomacy.”
At the end of 2020, when the world urgently needed COVID-19 vaccines, China launched its vaccine diplomacy by providing a large number of Chinese vaccines to low- and middle-income countries in Asia, Latin America, Africa and Eastern Europe.
However, according to the United Nations Children’s Fund (UNICEF), the export of COVID-19 vaccine developed and produced by three Chinese companies, Sinopharm, Sinovac, and CanSino dropped to 6.78 million doses in April 2022,  a 97 percent decrease from its peak in September 2021.

Leave a Comment

Your email address will not be published. Required fields are marked *